Shekam Raises Prices of Its Active Pharmaceutical Ingredients by an Average of 22 Percent
Sahmino Newsroom | 27 September 2026 | 2 months ago
The Farabourse-listed company under the ticker Shekam said in a Group B material disclosure filed on Codal on Saturday, September 26, 2026 (4 Mehr 1405), that its board has approved an average 22 percent increase in the prices of its active pharmaceutical ingredient products, effective from the date of approval. The filing dates the event to 4 Mehr 1405.
The company attributed the increase to higher raw material purchase prices, the removal of preferential currency for import orders of some raw materials, higher foreign and domestic freight costs, and rising energy and production overhead costs, saying the aim is to protect its profit margin. The filing puts the matter at 8 percent of the previous fiscal year's sales revenue and 7 percent of total assets. Shekam closed Saturday's session up 2.34 percent at 10,510 rials.
Sahmino context
What the prices have done since this story was published, and what Sahmino wrote around it
Since this story was published, KICZ rose 93 percent, to 20,420 rials.
Over the same days, Tehran Stock Exchange Index rose 14 percent, to 8,262,714.
Over the same days, US Dollar rose 14 percent, to 2,689,600 rials.
- KICZ
- +93.2%
- Tehran Stock Exchange Index
- +13.6%
- US Dollar
- +14.5%
Prices to the close of 21 November
From Sahmino that week
Iran Aluminium trades at a P/E near 6, under half its group: spring profit rose 7.7x, but monthly sales in Tir and Mordad ran 39% below the spring pace (Sunday, September 27, 2026)
Article | 27 SeptemberMajor holder exits DAFI: Sepehr Sodmandsina Investment Fund
Calendar | 27 SeptemberDividend payment: GSBE
Calendar | 27 SeptemberMaroon's 183 Percent Bonus Issue Did Not Change the Company's Value, but 13 Sessions of Buy Queues Lifted Its P/E From 5.4 to 7.9 (Saturday, 26 September 2026)
Article | 26 September
More from this market
Shokam Raises Prices of Some Products by Between 17 and 36 Percent
Stocks | 3 months agoKimiagaran Emrouz (KICZ) Raises Prices on Four Product Groups by 10% to 33%, With Propylene Glycols Up the Most
Stocks | 5 days agoKICZ Fails to Win Controlling Stake in Rishmak
Stocks | 14 days agoBank Day Books a 151.8 Billion Rial Gain From Selling 11 Surplus Properties at Auction
Stocks | 2 months ago
